Samsara BioCapital partners with scientific founders and entrepreneurs to translate cutting‑edge science into transformative medicines. They focus on companies developing innovative, differentiated therapies that address unmet medical needs, providing long‑term capital and hands‑on support throughout the full risk cycle.
Industries
Industry breakdown
Top industries in the portfolio
Geography
Geographic scope
United States
Geography breakdown
Darker regions = more portfolio companies
Top 5 countries
United States of America
71.4%United Kingdom
8.2%Canada
2.0%Switzerland
2.0%Denmark
2.0%Other
4.0%Countries with a higher share of the portfolio are shaded darker on the map.
Stages
Stage indicator
No stages listed
Stage breakdown
Portfolio by stage
Portfolio vintage
Companies by founded year
Fund details
Funds
Fund
Vintage 2018 • $310.0M
SMSR B1, L.P.
$80.5M
Samsara Biocapital, L.P.
$1.4B
565 SPV I, L.P.
$39.3K